An underground market for unapproved weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.
Experimental Drug Gaining Traction Online
Retatrutide, which remains in clinical trials, is being promoted by online personalities for its supposed weight-reducing properties. Followers are encouraged to message these accounts directly for supplier links, while also obtaining discount codes.
Thriving Trade on Messaging Platforms
Separately, a flourishing market exists on messaging services, where communities with thousands of members share comparison images, injection guides and claims of next-day British shipping. Vendors promote the substance there before redirecting buyers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Experts Voice Worries
Nevertheless, physicians and chemists have cautions that the sale of what is still an unlicensed drug in the UK is a cause for concern and could result in individuals administering products of uncertain source.
Several professionals said the popularity for the experimental drug could be linked to the rising cost of approved weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the British medical regulations.
Several influencers try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach medicines, marketing, and consumer laws, potentially leading to fines, prosecution or imprisonment.
Platform Response and Material Removal
According to TikTok, the platform has removed problematic content and prohibited related hashtags and query recommendations. The organization said it was committed to keeping the platform safe and allocating resources in strengthening compliance measures.
Digital Trading Activities
Investigations also discovered communities with up to 9,000 participants marketing retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” instantly brings up groups with thousands of members, filled with images of slimming results, positive reviews and step-by-step instructions for preparing or injecting at residence.
After moments of joining one group, a vendor shared contact information, where the majority of transactions take place. The seller sent an instruction manual and guaranteed shipping within two days. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one inquired about weight, medical conditions or previous experience.
Product Details and Pricing
Inside these communities, posts show black plastic parcels with postal service stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with sterile water, or pre-filled pens usually sold at £160 for 20mg. When asked how long a injector should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A representative for Telegram said it actively moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting materials they cannot confirm. Even if the science behind this drug is sound, these digital products may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the surge in demand to current cost increases for authorized weight-loss medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But fake treatments are extremely risky. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.
Her team has previously seen individuals injured by personal administration from unverified suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Statement
A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may subject users to potentially serious medical dangers”.
